Literature DB >> 18216721

Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population.

Laxi Zhang1, Hu Ding, Jiangtao Yan, Rutai Hui, Wei Wang, Grace E Kissling, Darryl C Zeldin, Dao Wen Wang.   

Abstract

OBJECTIVE: Epoxyeicosatrienoic acids have been recognized for their protective effects on the cardiovascular system. This study investigated whether two common polymorphisms in genes believed to be influential in regulating circulating levels of epoxyeicosatrienoic acids, namely cytochrome P450 2J2 (CYP2J2) G-50T and soluble epoxide hydrolase (EPHX2) G860A, were associated with ischemic stroke risk in a Chinese population. METHODS AND
RESULTS: Screening of 200 patients with ischemic stroke and 350 control participants revealed that CYP2J2-50T allele frequency was not significantly different in ischemic stroke cases versus controls. In contrast, EPHX2 860A allele frequency was 16.8% in ischemic stroke cases versus 21.7% in controls (P=0.047), and the presence of this variant allele was associated with a significantly lower risk of ischemic stroke after adjustment for sex, age and multiple cardiovascular risk factors (adjusted odds ratio=0.50, 95% confidence interval 0.29-0.86). Moreover, there was a significant interaction between the EPHX2 G860A polymorphism, smoking and ischemic stroke risk such that nonsmokers carrying the EPHX2 G860A variant allele were at the lowest risk of ischemic stroke (odds ratio=0.33, 95% confidence interval, 0.17-0.67, P=0.002), whereas no significant association was observed in smokers.
CONCLUSIONS: Collectively, these data indicate a protective influence of the G860A polymorphism of EPHX2 on ischemic stroke in Chinese nonsmokers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216721      PMCID: PMC2367218          DOI: 10.1097/FPC.0b013e3282f313e8

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  41 in total

Review 1.  Epoxygenase pathways of arachidonic acid metabolism.

Authors:  D C Zeldin
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

2.  Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids.

Authors:  K Node; X L Ruan; J Dai; S X Yang; L Graham; D C Zeldin; J K Liao
Journal:  J Biol Chem       Date:  2001-02-22       Impact factor: 5.157

3.  Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

Authors:  Z Yu; F Xu; L M Huse; C Morisseau; A J Draper; J W Newman; C Parker; L Graham; M M Engler; B D Hammock; D C Zeldin; D L Kroetz
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

4.  Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

Authors:  Benjamin B Davis; David A Thompson; Laura L Howard; Christophe Morisseau; Bruce D Hammock; Robert H Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

Review 5.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase.

Authors:  J H Capdevila; J R Falck; R C Harris
Journal:  J Lipid Res       Date:  2000-02       Impact factor: 5.922

6.  Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.

Authors:  John D Imig; Xueying Zhao; Jorge H Capdevila; Christophe Morisseau; Bruce D Hammock
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

7.  Cloning of CYP2J2 gene and identification of functional polymorphisms.

Authors:  Lorraine M King; Jixiang Ma; Supawon Srettabunjong; Joan Graves; J Alyce Bradbury; Leping Li; Martin Spiecker; James K Liao; Harvey Mohrenweiser; Darryl C Zeldin
Journal:  Mol Pharmacol       Date:  2002-04       Impact factor: 4.436

8.  Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation.

Authors:  C J Sinal; M Miyata; M Tohkin; K Nagata; J R Bend; F J Gonzalez
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

Review 9.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

10.  Soluble epoxide hydrolase: a novel therapeutic target in stroke.

Authors:  Wenri Zhang; Ines P Koerner; Ruediger Noppens; Marjorie Grafe; Hsing-Ju Tsai; Christophe Morisseau; Ayala Luria; Bruce D Hammock; John R Falck; Nabil J Alkayed
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-18       Impact factor: 6.200

View more
  32 in total

1.  Association of CYP2J2 gene polymorphisms with ischemic stroke.

Authors:  Qing Li; Jian-Hua Zhao; Peng-Ju Ma; Lin-Lin Su; Sheng-Bo Tao; Si-Bei Ji
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.

Authors:  Eric A Evangelista; Rüdiger Kaspera; Nahush A Mokadam; J P Jones; Rheem A Totah
Journal:  Drug Metab Dispos       Date:  2013-09-10       Impact factor: 3.922

Review 3.  Cytochrome P450 eicosanoids and cerebral vascular function.

Authors:  John D Imig; Alexis N Simpkins; Marija Renic; David R Harder
Journal:  Expert Rev Mol Med       Date:  2011-03-01       Impact factor: 5.600

Review 4.  Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders.

Authors:  Sydney Zarriello; Julian P Tuazon; Sydney Corey; Samantha Schimmel; Mira Rajani; Anna Gorsky; Diego Incontri; Bruce D Hammock; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2018-11-14       Impact factor: 11.685

5.  Role of soluble epoxide hydrolase in age-related vascular cognitive decline.

Authors:  Jonathan W Nelson; Jennifer M Young; Rohan N Borkar; Randy L Woltjer; Joseph F Quinn; Lisa C Silbert; Marjorie R Grafe; Nabil J Alkayed
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-09-30       Impact factor: 3.072

6.  Endothelium-derived hyperpolarizing factor in the brain: influence of sex, vessel size and disease state.

Authors:  Catherine M Davis; Dominic A Siler; Nabil J Alkayed
Journal:  Womens Health (Lond)       Date:  2011-05

7.  Assessment of soluble epoxide hydrolase activity in vivo: A metabolomic approach.

Authors:  Darko Stefanovski; Pei-An Betty Shih; Bruce D Hammock; Richard M Watanabe; Jang H Youn
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-01-10       Impact factor: 3.072

8.  Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population.

Authors:  Shehnaz Sultana; Venkata Karunakar Kolla; Vidyullatha Peddireddy; Yasovanthi Jeedigunta; Pranay K Penagaluru; Sindhu Joshi; Usha Rani Penagaluru; Pardhananda Reddy Penagaluru
Journal:  Transl Stroke Res       Date:  2011-01-20       Impact factor: 6.829

9.  Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent.

Authors:  Jeffrey J Iliff; Nabil J Alkayed
Journal:  Future Neurol       Date:  2009-03-01

Review 10.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.